Cargando…
Myogenic tissue nanotransfection improves muscle torque recovery following volumetric muscle loss
This work rests on our non-viral tissue nanotransfection (TNT) platform to deliver MyoD (TNT(MyoD)) to injured tissue in vivo. TNT(MyoD) was performed on skin and successfully induced expression of myogenic factors. TNT(MyoD) was then used as a therapy 7 days following volumetric muscle loss (VML) o...
Autores principales: | Clark, Andrew, Ghatak, Subhadip, Guda, Poornachander Reddy, El Masry, Mohamed S., Xuan, Yi, Sato, Amy Y., Bellido, Teresita, Sen, Chandan K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585072/ https://www.ncbi.nlm.nih.gov/pubmed/36266362 http://dx.doi.org/10.1038/s41536-022-00259-y |
Ejemplares similares
-
Nanotransfection-based vasculogenic cell reprogramming drives functional recovery in a mouse model of ischemic stroke
por: Lemmerman, Luke R., et al.
Publicado: (2021) -
Targeting Persister Hyperbiofilm Forming Bacterial Infection: The GelATA Wound Care Dressing
por: El Masry, Mohamed Salah, et al.
Publicado: (2022) -
Myogenic differentiation of human amniotic mesenchymal cells and its
tissue repair capacity on volumetric muscle loss
por: Zhang, Di, et al.
Publicado: (2019) -
P19. INHIBITION OF MICRORNA 126 LEADS TO COMPLETE REGRESSION OF HEMANGIOENDOTHELIOMA TUMORS IN MICE
por: Gordillo, Gayle M., et al.
Publicado: (2022) -
Arsenic Inhibits Myogenic Differentiation and Muscle Regeneration
por: Yen, Yuan-Peng, et al.
Publicado: (2010)